» Articles » PMID: 34322416

Serum Vitamin B12 Status of Patients with Type 2 Diabetes Mellitus on Metformin: A Single-center Cross-sectional Study from Bangladesh

Overview
Specialty Public Health
Date 2021 Jul 29
PMID 34322416
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Metformin use is a known cause of B12 deficiency in patients with type 2 DM (T2DM). Diabetic peripheral neuropathy (DPN) often has clinically indistinguishable clinical features of B12 deficiency-induced peripheral neuropathy (PN).

Objective: The present study aims to assess serum vitamin B12 levels in patients with T2DM on metformin.

Subjects And Methods: This cross-sectional study was conducted at a specialized endocrine outpatient clinic in Cumilla, Bangladesh, over six months from January 2020 to June 2020. Non-pregnant adults (≥18 years age) receiving metformin for T2DM for at least six months were evaluated for PN and assessed for serum B12 levels.

Results: Among 90 subjects evaluated, 28 (31.1%) had B12 deficiency and 6 (6.7%) had borderline B12 deficiency; 56 (62.2%) had normal B12 levels. Study subjects with subnormal B12 used metformin for a longer duration [8.5 (7.0-14.0) vs. 5.0 (2.25-10.0) years, median (IQR), = 0.006], gram-years of metformin use was higher in them [12.0 (7.9-14.0) vs. 5.75 (2.0-13.6) years, median (IQR), = 0.005] and they had a higher mean corpuscular volume [85.9±7.2 vs. 82.4±6.4 fL, mean±SD, = 0.020] compared to those having normal B12 levels. Serum B12 levels had a strong negative correlation with duration of metformin use and gram-years of metformin use. B12 status did not influence the presence and severity of PN.

Conclusions: A considerable number of patients with T2DM have subnormal B12 levels. Periodic screening for serum vitamin B12 level may be of clinical benefit in such patients.

References
1.
Kim J, Ahn C, Fang S, Lee H, Park J . Association between metformin dose and vitamin B12 deficiency in patients with type 2 diabetes. Medicine (Baltimore). 2019; 98(46):e17918. PMC: 6867725. DOI: 10.1097/MD.0000000000017918. View

2.
Wile D, Toth C . Association of metformin, elevated homocysteine, and methylmalonic acid levels and clinically worsened diabetic peripheral neuropathy. Diabetes Care. 2009; 33(1):156-61. PMC: 2797962. DOI: 10.2337/dc09-0606. View

3.
Davies M, DAlessio D, Fradkin J, Kernan W, Mathieu C, Mingrone G . Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2018; 41(12):2669-2701. PMC: 6245208. DOI: 10.2337/dci18-0033. View

4.
Selhub J, Morris M, Jacques P, Rosenberg I . Folate-vitamin B-12 interaction in relation to cognitive impairment, anemia, and biochemical indicators of vitamin B-12 deficiency. Am J Clin Nutr. 2009; 89(2):702S-6S. PMC: 2647758. DOI: 10.3945/ajcn.2008.26947C. View

5.
Alvarez M, Sierra O, Saavedra G, Moreno S . Vitamin B12 deficiency and diabetic neuropathy in patients taking metformin: a cross-sectional study. Endocr Connect. 2019; 8(10):1324-1329. PMC: 6790897. DOI: 10.1530/EC-19-0382. View